Smoking and Respiratory Diseases in Patients with Coronary Microvascular Dysfunction
The American Journal of Medicine,
Journal Year:
2024,
Volume and Issue:
137(6), P. 538 - 544.e1
Published: March 12, 2024
Language: Английский
Nanotechnology safety in biomedical industry
Abdulhammed K. Hamzat,
No information about this author
Md Shafinur Murad,
No information about this author
Eylem Asmatulu
No information about this author
et al.
Elsevier eBooks,
Journal Year:
2025,
Volume and Issue:
unknown, P. 97 - 113
Published: Jan. 1, 2025
Language: Английский
A tale as old as time – the importance of accelerated lung aging in chronic obstructive pulmonary disease
Expert Review of Respiratory Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 13, 2025
Chronic
obstructive
pulmonary
disease
(COPD)
is
progressive
in
nature
and
predominantly
affects
older
individuals.
Lung
function
decline
a
typical
part
of
the
aging
process,
characterized
by
gradual
loss
lung
mechanics,
airway
remodeling,
persistent
low-grade
inflammation
airways,
compromised
epithelial
barrier
function,
impaired
immune
responses
over
time.
The
pathology
senile
advanced
patients
with
COPD,
whereby
genomic
damages
contribute
to
structural
defects
cellular
dysfunction.
Primary,
antagonistic
integrative
hallmarks
are
accelerated
potentiated
cumulative
injury
sustained
from
repeated
environmental
exposures
interaction
comorbidities.
Identification
epigenetic
profiles
COPD
indicates
how
processes
advancement
biological
age.
Epigenetic
abnormalities
unique
subpopulations
occur
individuals
who
immunodeficient,
often
experience
early
onset
increased
severity
COPD.
Accelerated
indicated
other
biomarkers
may
be
promising
avenue
for
detection,
prevention,
subsequent
management
Understanding
risk
factors
contributing
implementation
mitigation
strategies
such
as
cessation
smoking,
repurposing
existing
pharmacotherapeutics
development
novel
therapies
slow
age-related
pathologies
Language: Английский
The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease
Qinghua Luo,
No information about this author
Ping Zhou,
No information about this author
Shuangqing Chang
No information about this author
et al.
Heart & Lung,
Journal Year:
2023,
Volume and Issue:
61, P. 120 - 126
Published: May 27, 2023
Language: Английский
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(11), P. 3834 - 3834
Published: June 3, 2023
In
heart
failure
with
reduced
ejection
fraction,
edema
and
congestion
are
related
to
cardiac
function.
Edema
further
aggravated
by
chronic
kidney
pulmonary
abnormalities.
Furthermore,
together
edema/congestion,
sodium/water
retention
is
an
important
sign
of
the
progression
failure.
Edema/congestion
often
anticipates
clinical
symptoms,
such
as
dyspnea
hospitalization;
it
associated
a
quality
life
major
risk
mortality.
It
very
for
clinicians
predict
signs
biomarkers
and,
mainly,
understand
pathophysiological
findings
that
underlie
edema.
Not
all
congestions
secondary
failure,
in
nephrotic
syndrome.
This
review
summarizes
principal
evidence
on
possible
roles
old
new
HFrEF
patients
(diagnostic,
prognostic,
therapeutic
roles).
we
provide
description
conditions
other
than
increased
biomarkers,
order
aid
reaching
differential
diagnosis.
To
conclude,
focuses
how
may
be
affected
HF
drugs
(gliflozins,
vericiguat,
etc.)
approved
HFrEF.
Language: Английский
Circadian rhythm and variability of large and small airway spirometric variables in healthy individuals
Digital Health,
Journal Year:
2024,
Volume and Issue:
10
Published: Jan. 1, 2024
To
assess
the
diurnal
rhythm
and
variability
of
lung
function
in
healthy
individuals,
encompassing
both
large
small
airways.
Language: Английский
Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections
Giorgio Ciprandi,
No information about this author
Attilio Varriccchio
No information about this author
Children,
Journal Year:
2023,
Volume and Issue:
10(7), P. 1210 - 1210
Published: July 12, 2023
Respiratory
tract
infections
(RTIs)
are
usually
characterized
by
mucus
hypersecretion.
This
condition
may
worsen
and
prolong
symptoms
signs.
For
this
reason,
reducing
production
improving
removal
represent
relevant
aspects
of
managing
patients
with
RTIs.
In
regard,
mucoactive
drugs
be
effective.
Mucoactive
agents
constitute
a
large
class
compounds
different
mechanisms
action.
Sobrerol
is
monoterpene
able
to
fluidify
mucus,
increase
mucociliary
clearance,
exert
antioxidant
activity.
available
in
various
formulations
(granules,
syrup,
nebulized,
suppository).
has
been
on
the
market
for
over
50
years.
Therefore,
present
article
revised
evidence
concerning
compound
proposed
new
possible
strategies.
The
literature
analysis
showed
that
several
studies
investigated
efficacy
safety
sobrerol
acute
chronic
RTIs
hyperproduction.
Seven
pediatric
have
conducted
favorable
outcomes.
However,
regulatory
agencies
recently
reduced
treatment
duration
three
days.
future
study
will
test
hypothesis
combination
oral
topical
could
benefit
children
adults
frequent
respiratory
infections.
rationale
approach
based
concept
accumulation
risk
factor
increased
susceptibility
Language: Английский
Monocyte to eosinophil ratio as a diagnostic biomarker for overlap syndrome and predictor of disease exacerbation
International Journal of Immunopathology and Pharmacology,
Journal Year:
2023,
Volume and Issue:
37
Published: Jan. 1, 2023
Objectives:
Chronic
Obstructive
Pulmonary
Disease
(COPD)
is
one
of
the
most
common
pulmonary
diseases.
The
concomitant
association
Sleep
Apnea
(OSA)
and
COPD
known
as
Overlap
Syndrome
(OS).
This
study
aimed
to
identify
markers
for
predicting
OS,
among
routine
laboratory
tests,
including
differential
blood
counts.Methods:
One
hundred
twenty-five
patients
with
exacerbated
were
enrolled
in
screened
OSA
using
Epworth
Sleepiness
Scale
(ESS).
Those
a
positive
ESS
score
underwent
polysomnography
(PSG)
confirmation.
All
followed
90
days
monitor
subsequent
exacerbations.Results:
Out
125
COPD,
25
confirmed
have
OSA.
OS
had
significantly
higher
body
mass
index
(BMI)
(p
<
0.001).
monocyte
eosinophil
ratio
(MER)
was
group,
while
neutrophil
(NMR)
platelets
(PMR)
lower.
Younger
age,
male
sex,
all
associated
OS.
During
90-day
follow-up
period
after
hospital
discharge,
60%
re-admitted
due
acute
exacerbations.
hazard
second
exacerbation
increased
by
two-fold
every
one-unit
increase
MER.
MER
demonstrated
excellent
utility
exacerbation,
an
area
under
curve
(AUC)
83%
p-value
.005.Conclusion:
independent
predictors
very
good
prognostic
next
episodes.
Long
term
follow
up
recommended
evaluate
severity
exacerbations
effect
complications
on
morbidity
mortality
these
patients.
Language: Английский
The Added Value of Bronchoalveolar Lavage for Pulmonary Tuberculosis Diagnosis in High-Risk Hospitalized Patients with Negative Sputum Samples
Ophir Freund,
No information about this author
Yitzhac Hadad,
No information about this author
Tomer Lagziel
No information about this author
et al.
Advances in respiratory medicine,
Journal Year:
2023,
Volume and Issue:
92(1), P. 15 - 24
Published: Dec. 21, 2023
Hospitalized
patients
with
a
high
suspicion
of
pulmonary
tuberculosis
(HS-PTB)
are
isolated
until
definite
diagnosis
can
be
determined.
If
doubt
remains
after
negative
sputum
samples,
bronchoscopy
bronchoalveolar
lavage
(BAL)
is
often
sought.
Still,
evidence
the
added
value
BAL
in
this
patient
population
scarce.
To
address
issue,
we
included
consecutive
HS-PTB
samples
who
underwent
between
2017
and
2018.
Chest
X-rays
(CXR)
CT
scans
were
evaluated
by
chest
radiologist
blind
to
final
diagnosis.
Independent
predictors
for
PTB
assessed
multivariate
regression,
using
all
positive
2019
(by
or
BAL)
as
control
group
(n
=
41).
Overall,
42
(mean
age
51
±
9,
36%
female).
was
viable
diagnostic
three
(7%)
cases
other
clinically
relevant
pathogens
six
(14%).
≥2
sub-acute
symptoms
(adjusted
OR
3.18,
95%
CI
1.04–9.8),
CXR
upper-lobe
consolidation
(AOR
8.70,
2.5–29),
centrilobular
nodules
3.96,
1.20–13.0,
p
0.02).
In
conclusion,
hospitalized
had
7%
samples.
Our
findings
highlight
specific
that
could
used
future
controlled
studies
personalize
evaluation.
Language: Английский